Clinical Trial

Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN）

Name: Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN） — clinical trial record (NCT07278674)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CSHEIN

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

Evaluate the impact of maintenance therapy with eflornithine on event-free survival and overall survival in high-risk neuroblastoma (NB) children after immunotherapy, and assess its safety.

Trial Details

NCT Number	NCT07278674
Lead Sponsor	Shanghai Children's Hospital Collaborators: Ruijin Hospital
Conditions	High Risk Neuroblastoma
Enrollment	20 participants
Start Date	2025-04-08
Primary Completion	2029-10-31 (estimated)
Study Completion	2029-10-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-12